
Adv J Biom Sci
An international, peer-reviewed, open access journal of the molecular basis of disease and biomedical laboratory science, published online since 2016
Journal DOI 10.21065/AdvJBiomedSci · Abbreviation: Adv J Biomed Sci · Published annually in English
The Advanced Journal of Biomedical Sciences publishes research on the fundamental and molecular basis of human disease, and on the laboratory sciences used to diagnose, monitor and treat it. Its emphasis is on molecular studies of biomedical problems. These include how changes in genes, proteins, cells and tissues lead to disease, and how such changes can be detected accurately in the laboratory.
The journal serves biomedical scientists, clinical laboratory professionals, pathologists and researchers in the basic medical sciences. It contributes to public health and promotes the proper conduct of scientific research. All articles are free to read, download and reuse from the day of publication.
Title: Advanced Journal of Biomedical Sciences
Abbreviation: Adv J Biomed Sci
Journal DOI (Crossref): https://doi.org/10.21065/AdvJBiomedSci
Zenodo DOI: https://doi.org/10.5281/zenodo.15098536
First published: 2016
Frequency: Annual (articles published online on acceptance)
Format: Online only
Language: English
Peer review: Double-blind, at least two reviewers
Licence: CC BY 4.0
Copyright: Journal, publisher and authors (jointly held)
Publication charges: No submission fee; APC CA$100 (after acceptance)
Submission: Online
Publisher: Consortium Publisher – ICDTD Inc., Canada
Contact: office@consortiumpublisher.ca · +1 (647) 526-0885
The journal publishes original work that explains the molecular and cellular mechanisms of disease, or that improves how disease is detected and monitored in the laboratory. It values research that links a clear biomedical question to sound methods, appropriate controls and validated assays, with conclusions supported by the data. Acceptance depends mainly on scientific rigour and the potential to advance the field.
The journal aims to:
Publish reproducible research on the molecular and cellular basis of human disease.
Connect basic biomedical science with laboratory diagnosis, patient care and public health.
Provide a forum where researchers in universities, hospitals and industry exchange findings and methods.
Make every article openly available, so that researchers, laboratory professionals, clinicians, educators and students everywhere can use it without cost.
Within scope: studies that test a hypothesis about a disease mechanism, or that develop and validate a laboratory method, using appropriate controls, replication and statistical analysis. This includes work on patient samples, tissues, primary cells, cell lines, microorganisms and animal models. Case reports with a laboratory or molecular investigation are also within scope.
Outside scope: clinical case reports with no laboratory or molecular investigation, and studies of clinical management with no biomedical mechanism. Unvalidated assays are also outside scope, as are studies whose conclusions rest on data that are not made available for review.
The subject areas are grouped into nine themes. They run from genes and molecules, through blood, infection and tissues, to the function of the whole body and the quality of the tests used to study it.
1. Molecular and cell biology and genetics. Molecular and cell biology, molecular genetics and cytogenetics, and bioinformatics. This theme asks how genes, molecules and cells cause or protect against disease.
2. Biochemistry and clinical biochemistry. Biochemistry, clinical biochemistry and biomedical biotechnology. This theme asks how biochemical changes reveal and drive disease, and how they are measured.
3. Haematology and transfusion science. Haematology, haemostasis and thrombosis, blood transfusion science and phlebotomy. This theme asks how blood cells and clotting go wrong, and how blood testing and transfusion can be made safer.
4. Immunology and infection science. Clinical immunology, and microbiology, including bacteriology, mycology, virology and tropical diseases. This theme asks how pathogens cause disease, how the immune system responds, and how infections are diagnosed.
5. Cellular and molecular pathology. Histopathology and cytopathology, cervical cytology, molecular pathology and electron microscopy. This theme asks how changes in tissues and cells reveal disease, and how diagnosis can be made more accurate.
6. Reproductive science, transplantation and tissue banking. Clinical embryology, histocompatibility and immunogenetics, tissue banking and transplantation science. This theme asks how cells and tissues can be matched, preserved and used safely in reproduction and transplantation.
7. Physiological sciences. Human physiology, and audiology and hearing science. This theme asks how organs and body systems function, and how that function is measured in patients.
8. Pharmacology, toxicology and patient safety. Molecular toxicology, pharmaceutical sciences and pharmacotherapy as they relate to disease mechanisms, environmental health, and the safety of medicines and medical products. This theme asks how drugs and toxic agents act at the molecular level, and how medicines and medical products can be made safer.
9. Laboratory quality, biometrics and models. External quality assurance, method validation, biometrics, and theoretical models of health and disease. This theme asks how laboratory results can be made accurate, reliable and comparable, and how they can be modelled.
Work from university, hospital, public health and industry laboratories is welcome in every theme.
Original research article: reports new experimental, laboratory or computational findings that test a defined hypothesis.
Review article: critically synthesises published evidence on a topic and identifies open questions. Systematic reviews should follow PRISMA.
Case report: describes a patient or case with a laboratory or molecular investigation that adds new knowledge. Case reports should follow the CARE guidelines.
Laboratory method: describes a new or substantially improved assay, technique or protocol, with full validation data.
Short communication: reports a focused, significant finding that does not need a full article.
Expository article: explains an important biomedical topic or technique clearly for a broad readership. Expository articles are especially encouraged.
Commentary or letter: offers an evidence-based viewpoint on a current issue, or responds briefly to an article published in the journal.
All article types are peer reviewed except editorials, letters and corrections. Editors may propose special issues on a defined topic. Special issue papers go through the same peer review, and guest editors do not handle their own submissions.
The Advanced Journal of Biomedical Sciences is a fully open access journal that follows the Directory of Open Access Journals (DOAJ) definition of open access. All articles are free to read immediately on publication, with no subscription, registration or embargo.
Licence. Articles are published under the Creative Commons Attribution 4.0 International licence (CC BY 4.0). Anyone may read, download, copy, distribute, print, search or link to the full text, crawl it for indexing, pass it as data to software, or use it for any other lawful purpose, as long as the original authors and source are properly cited. The licence statement appears on every article page and in the article PDF.
Copyright. The journal, the publisher (Consortium Publisher – ICDTD Inc.) and the authors hold copyright of each article jointly. The journal has the right to publish the article first. Because articles are published under CC BY 4.0, anyone may reuse them with proper citation. Authors may deposit any version of their article, including the published version, in institutional or subject repositories at any time.
Third-party material. Authors must get permission for any figures, micrographs, tables or text reused from other sources and label them with their original licence.
There is no charge to read any article, and there is no submission fee.
Article processing charge (APC): CA$100. It is charged only after a manuscript is accepted, never for submission or review. The APC applies to manuscripts submitted from 1 July 2026. Manuscripts submitted up to 30 June 2026 are exempt.
The APC never influences editorial decisions. Full or partial waivers are available on request for authors from low- and middle-income countries and for authors without funding.
Every research and review manuscript is assessed by at least two independent expert reviewers under a double-blind model. Reviewers do not know the authors’ identities, and authors do not know the reviewers’. Decisions rest on scientific validity, methodological soundness, ethical compliance and contribution to the field, not on the expected impact or citation of the work.
Editorial independence. An editor with a conflict of interest in a manuscript does not handle it. This includes manuscripts from the editor’s own institution and the editor’s own submissions. Such manuscripts are assigned to another editor and reviewed under the same process. The publisher does not take part in editorial decisions.
The journal follows the Core Practices of the Committee on Publication Ethics (COPE) and the ICMJE Recommendations for the conduct, reporting and editing of scholarly work.
Originality and plagiarism. Every submission is screened for text similarity before review. Plagiarism, duplicate publication and redundant publication lead to rejection or, after publication, retraction.
Image and data integrity. Figures, including blots, gels, micrographs and flow cytometry plots, must not be altered in ways that misrepresent the original data. Editors may request original, unprocessed images.
Human research and samples. Studies involving people, patient samples or clinical data must have approval from a named ethics committee and record informed consent, or a documented waiver for residual or archived samples. They must follow the Declaration of Helsinki and Canada’s TCPS 2. Patient data must be de-identified.
Case reports. The patient’s written consent to publication is required.
Clinical trials and reporting standards. Clinical trials must be registered in a public registry before enrolment begins and reported according to CONSORT. Diagnostic accuracy studies should follow STARD.
Animal research. Studies involving animals must have institutional approval, follow the Canadian Council on Animal Care (CCAC) guidelines or an equivalent, and be reported according to ARRIVE.
Biosafety and cell lines. Work with pathogens or biological hazards must follow the applicable biosafety regulations, such as the Canadian Biosafety Standard. Cell lines should be authenticated and tested for mycoplasma, with the results reported.
Authorship. All authors must meet the ICMJE authorship criteria. Authors are encouraged to describe each contribution using the CRediT taxonomy and to provide an ORCID iD.
Conflicts of interest and funding. Authors must disclose all funding and any financial or professional interest that could affect the work. This includes links to diagnostic, pharmaceutical or medical device companies.
Data availability. Each article includes a data availability statement. Sequence, expression and other omics data must be deposited in an appropriate public repository, such as GenBank or GEO.
Use of artificial intelligence. AI tools cannot be listed as authors. Any use of AI in research or writing must be disclosed in the Methods or Acknowledgements, and authors remain responsible for all content.
Corrections and retractions. Errors are corrected through linked correction notices. Retractions follow COPE guidelines and remain openly accessible, with the reason stated.
Complaints and appeals. Authors may appeal a decision by writing to the editorial office with their reasons. Concerns about published work are handled according to the COPE flowcharts.
Every article receives a permanent Digital Object Identifier (DOI) registered with Crossref under the journal DOI 10.21065/AdvJBiomedSci. The DOI means an article can always be found and cited, even if web addresses change. Journal records are also deposited in Zenodo (https://doi.org/10.5281/zenodo.15098536).
Machine-readable metadata. Article metadata is deposited with Crossref, so indexing services and software can harvest it. The metadata includes titles, authors, affiliations, abstracts, references, licence and funding.
Manuscripts are submitted and processed online, and authors can follow each stage of review in their account. The journal is published by Consortium Publisher – ICDTD Inc., Canada. Its website is hosted on Bravo Journal Systems (BJS) of Bravo Skills College, Port of Spain, Trinidad and Tobago.
Before submitting, please read the Author Guidelines and prepare a cover letter. Include statements on ethics approval, consent, trial registration where relevant, funding, conflicts of interest and data availability.
[Submit a manuscript] · [Author Guidelines] · [Editorial Board] · [Contact the editorial office]